Abstract:'Reactive oxygen species' (ROS) is an umbrella term for an array of derivatives of molecular oxygen that occur as a normal attribute of aerobic life. Elevated formation of the different ROS leads to molecular damage, denoted as 'oxidative distress'. Here we focus on ROS at physiological levels and their central role in redox signalling via different post-translational modifications, denoted as 'oxidative eustress'. Two species, hydrogen peroxide (H2O2) and the superoxide anion radical (O2·−), are key redox signalling agents generated under the control of growth factors and cytokines by more than 40 enzymes, prominently including NADPH oxidases and the mitochondrial electron transport chain. At the low physiological levels in the nanomolar range, H2O2 is the major agent signalling through specific protein targets, which engage in metabolic regulation and stress responses to support cellular adaptation to a changing environment and stress. In addition, several other reactive species are involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids. Recent methodological advances permit the assessment of molecular interactions of specific ROS molecules with specific targets in redox signalling pathways. Accordingly, major advances have occurred in understanding the role of these oxidants in physiology and disease, including the nervous, cardiovascular and immune systems, skeletal muscle and metabolic regulation as well as ageing and cancer. In the past, unspecific elimination of ROS by use of low molecular mass antioxidant compounds was not successful in counteracting disease initiation and progression in clinical trials. However, controlling specific ROS-mediated signalling pathways by selective targeting offers a perspective for a future of more refined redox medicine. This includes enzymatic defence systems such as those controlled by the stress-response transcription factors NRF2 and nuclear factor-κB, the role of trace elements such as selenium, the use of redox drugs and the modulation of environmental factors collectively known as the exposome (for example, nutrition, lifestyle and irradiation).

Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease.

Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases.

The role of reactive oxygen species in myocardial redox signaling and regulation

ROS and ROS-Mediated Cellular Signaling

Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases

Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases

Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions—Diabetes Mellitus, Cardiovascular Diseases, and Ischemia–Reperfusion Injury

Cross-Talk between NADPH Oxidase and Mitochondria: Role in ROS Signaling and Angiogenesis

Reactive Oxygen Species and Oxidative Stress in Vascular-Related Diseases

Mitochondrial reactive oxygen species production and elimination

Reactive Oxygen Species: Key Regulators In Vascular Health And Diseases

Endothelial Cell Superoxide Generation: Regulation and Relevance for Cardiovascular Pathophysiology.

Reactive Oxygen Species in Cardiovascular Diseases: an Update

Redox control of the survival of healthy and diseased cells.

Redox Signaling at the Crossroads of Human Health and Disease

Reactive oxygen species: physiological roles in the regulation of vascular cells

The Interplay between Mechanoregulation and ROS in Heart Physiology, Disease, and Regeneration

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure

Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease

ROS-Induced Endothelial Dysfunction in the Pathogenesis of Atherosclerosis